Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Systemic Psoriasis Therapeutics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Systemic Psoriasis Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Systemic Psoriasis Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Johnson & Johnson
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
F Hoffmann-La Roche
Celgene
Amgen
Merck
Mitsubishi Tanabe Pharma
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Systemic Psoriasis Therapeutics Market
-
1.3 Market Segment by Type
1.3.1 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Systemic Psoriasis Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Systemic Psoriasis Therapeutics by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Systemic Psoriasis Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Systemic Psoriasis Therapeutics by Major End-Users
4.4.1 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Application 1
4.4.2 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Application 2
4.4.3 Market Size and Growth Rate of Systemic Psoriasis Therapeutics in Application 3
5 Market Analysis by Regions
-
5.1 Japan Systemic Psoriasis Therapeutics Production Analysis by Regions
-
5.2 Japan Systemic Psoriasis Therapeutics Consumption Analysis by Regions
6 Hokkaido Systemic Psoriasis Therapeutics Landscape Analysis
-
6.1 Hokkaido Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
6.2 Hokkaido Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
7 Tohoku Systemic Psoriasis Therapeutics Landscape Analysis
-
7.1 Tohoku Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
7.2 Tohoku Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
8 Kanto Systemic Psoriasis Therapeutics Landscape Analysis
-
8.1 Kanto Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
8.2 Kanto Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
9 Chubu Systemic Psoriasis Therapeutics Landscape Analysis
-
9.1 Chubu Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
9.2 Chubu Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
10 Kinki Systemic Psoriasis Therapeutics Landscape Analysis
-
10.1 Kinki Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
10.2 Kinki Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
11 Chugoku Systemic Psoriasis Therapeutics Landscape Analysis
-
11.1 Chugoku Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
11.2 Chugoku Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
12 Shikoku Systemic Psoriasis Therapeutics Landscape Analysis
-
12.1 Shikoku Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
12.2 Shikoku Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
13 Kyushu Systemic Psoriasis Therapeutics Landscape Analysis
-
13.1 Kyushu Systemic Psoriasis Therapeutics Landscape Analysis by Major Types
-
13.2 Kyushu Systemic Psoriasis Therapeutics Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Johnson & Johnson
14.1.1 Johnson & Johnson Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 AbbVie
14.2.1 AbbVie Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 F. Hoffmann-La Roche
14.3.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 GlaxoSmithKline
14.4.1 GlaxoSmithKline Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Pfizer
14.5.1 Pfizer Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 F Hoffmann-La Roche
14.6.1 F Hoffmann-La Roche Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Celgene
14.7.1 Celgene Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Amgen
14.8.1 Amgen Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Merck
14.9.1 Merck Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Mitsubishi Tanabe Pharma
14.10.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 100 Figures and 148 Tables)
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Systemic Psoriasis Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Systemic Psoriasis Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Systemic Psoriasis Therapeutics by Different Types from 2014 to 2026
-
Table Consumption Share of Systemic Psoriasis Therapeutics by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Systemic Psoriasis Therapeutics by Different End-Users from 2014 to 2026
-
Table Consumption Share of Systemic Psoriasis Therapeutics by Different End-Users from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Systemic Psoriasis Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Systemic Psoriasis Therapeutics Production by Regions
-
Table Japan Systemic Psoriasis Therapeutics Production Share by Regions
-
Figure Japan Systemic Psoriasis Therapeutics Production Share by Regions in 2014
-
Figure Japan Systemic Psoriasis Therapeutics Production Share by Regions in 2018
-
Figure Japan Systemic Psoriasis Therapeutics Production Share by Regions in 2026
-
Table Japan Systemic Psoriasis Therapeutics Consumption by Regions
-
Table Japan Systemic Psoriasis Therapeutics Consumption Share by Regions
-
Figure Japan Systemic Psoriasis Therapeutics Consumption Share by Regions in 2014
-
Figure Japan Systemic Psoriasis Therapeutics Consumption Share by Regions in 2018
-
Figure Japan Systemic Psoriasis Therapeutics Consumption Share by Regions in 2026
-
Table Hokkaido Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Hokkaido Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Hokkaido Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Hokkaido Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Tohoku Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Tohoku Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Tohoku Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Tohoku Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Tohoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Kanto Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Kanto Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Kanto Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kanto Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Kanto Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Chubu Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Chubu Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Chubu Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chubu Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Chubu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Kinki Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Kinki Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Kinki Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kinki Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Kinki Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Chugoku Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Chugoku Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Chugoku Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chugoku Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Chugoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Shikoku Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Shikoku Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Shikoku Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Shikoku Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Shikoku Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
-
Table Kyushu Systemic Psoriasis Therapeutics Consumption by Types from 2014 to 2026
-
Table Kyushu Systemic Psoriasis Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by Types in 2014
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by Types in 2018
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by Types in 2026
-
Table Kyushu Systemic Psoriasis Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kyushu Systemic Psoriasis Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2014
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2018
-
Figure Kyushu Systemic Psoriasis Therapeutics Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of F Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
Table Product and Service Introduction of F Hoffmann-La Roche
Table Company Profile and Development Status of Celgene
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
Figure Sales and Growth Rate Analysis of Celgene
Figure Revenue and Market Share Analysis of Celgene
Table Product and Service Introduction of Celgene
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
Table Company Profile and Development Status of Mitsubishi Tanabe Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma
Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma
Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma
Table Product and Service Introduction of Mitsubishi Tanabe Pharma
-
